Hanmi Pharm. Co., Ltd. in 1 story
The narratives 128940.KS currently appears in, with its side and exposure in each.
Bull side
1 story- GLP-1 Eats Everything
128940.KS in “GLP-1 Eats Everything”
FadingExposure: not rated yetAppetite suppression as a macro variable.
Hanmi has a differentiated obesity pipeline led by long-acting multi-agonist candidates targeting GLP-1, GIP and glucagon pathways.
Bear side
0 storiesNo bear-side stories for 128940.KS yet.